Literature DB >> 10210271

Protection of calcitonin gene-related peptide-mediated preconditioning against coronary endothelial dysfunction induced by reperfusion in the isolated rat heart.

F W Zhou1, Y J Li, R Lu, H W Deng.   

Abstract

This study was designed to explore the protective effect of ischemic preconditioning on reperfusion-induced coronary endothelial dysfunction, with a focus on the role of calcitonin gene-related peptide (CGRP) in this effect, in the isolated perfused rat heart. Thirty minutes of global ischemia and 30 min of reperfusion significantly decreased heart rate, left ventricular pressure, and its first derivative and impaired vasodilator responses to acetylcholine. Ischemia-reperfusion did not affect vasodilator responses to sodium nitroprusside. Preconditioning induced by three cycles of 5 min of ischemia and 5 min of reperfusion produced a significant improvement in cardiac function concomitantly with an amelioration of vasodilator responses to acetylcholine. The protective effects of ischemic preconditioning were abolished by CGRP(8-37) (10(-7) M) , the selective CGRP receptor antagonist. After pretreatment with capsaicin (50 mg x kg(-1), s.c.) to deplete endogenous CGRP, the preconditioning effect was absent. Pretreatment with exogenous CGRP (5 x 10(-9) M) for 5 min induced a preconditioning-like protection. The present study suggests that the cardioprotection of ischemic preconditioning is related to the preservation of the coronary endothelial cell, and that the protective effect of preconditioning is mediated by endogenous CGRP in the isolated perfused rat heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210271     DOI: 10.1016/s0024-3205(99)00037-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.

Authors:  Angel Luis García-Villalón; Yesika María Amezquita; Luis Monge; Nuria Fernández; Belén Climent; Ana Sánchez; Godofredo Diéguez
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

2.  Role of the transient receptor potential vanilloid type 1 receptor and stretch-activated ion channels in nitric oxide release from endothelial cells of the aorta and heart in rats.

Authors:  Juan Carlos Torres-Narváez; Leonardo Del Valle Mondragón; Elvira Varela López; Israel Pérez-Torres; Julieta Anabell Díaz Juárez; Jorge Suárez; Gustavo Pastelín Hernández
Journal:  Exp Clin Cardiol       Date:  2012-09

3.  Selective sensory denervation by capsaicin aggravates adriamycin-induced cardiomyopathy in rats.

Authors:  Márta Katona; Krisztina Boros; Péter Sántha; Péter Ferdinandy; Mária Dux; Gábor Jancsó
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-10       Impact factor: 3.000

4.  The Role of the Activation of the TRPV1 Receptor and of Nitric Oxide in Changes in Endothelial and Cardiac Function and Biomarker Levels in Hypertensive Rats.

Authors:  Juan Carlos Torres-Narváez; Israel Pérez-Torres; Vicente Castrejón-Téllez; Elvira Varela-López; Víctor Hugo Oidor-Chan; Verónica Guarner-Lans; Álvaro Vargas-González; Raúl Martínez-Memije; Pedro Flores-Chávez; Etzna Zizith Cervantes-Yañez; Claudia Angélica Soto-Peredo; Gustavo Pastelín-Hernández; Leonardo Del Valle-Mondragón
Journal:  Int J Environ Res Public Health       Date:  2019-09-25       Impact factor: 3.390

5.  TRPV1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion.

Authors:  Vicente Castrejón-Téllez; Leonardo Del Valle-Mondragón; Israel Pérez-Torres; Verónica Guarner-Lans; Gustavo Pastelín-Hernández; Angélica Ruiz-Ramírez; Julieta Anabell Díaz-Juárez; Elvira Varela-López; Víctor Hugo Oidor-Chan; Alvaro Vargas-González; Raúl Martínez-Memije; Pedro Flores-Chávez; Bruno León-Ruíz; Sergio Arriaga-Carrillo; Juan Carlos Torres-Narváez
Journal:  Molecules       Date:  2022-02-03       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.